Dermatouch Acnecare Facial Scrub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects mentioned associated with the use of this medication.

Dosage and Administration

The patient should begin by wetting the face thoroughly. A sufficient amount of the product should then be applied to the hands, followed by the addition of water to create a lather. The lather should be gently massaged onto the face, ensuring even coverage. After massaging, the face must be rinsed thoroughly with water.

Initially, the product is to be applied once daily. Based on individual response and as directed by a healthcare professional, the frequency of application may be gradually increased to two or three times daily. In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once a day or every other day.

Contraindications

The use of this product is contraindicated in patients who are concurrently using another topical acne medication, as this may lead to increased skin irritation and dryness. In the event of irritation, it is advised to limit the use to one topical acne medication at a time.

Warnings and Precautions

For external use only. The concurrent use of other topical acne medications may exacerbate skin dryness or irritation. In the event of increased discomfort, it is advised to limit the use to one topical acne medication unless otherwise directed by a healthcare professional.

Sensitivity Testing for New Users New users are recommended to perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days. If no discomfort is experienced, users may proceed with the application as directed.

General Precautions The likelihood of skin irritation and dryness is heightened when this product is used in conjunction with other topical acne treatments. Should irritation occur, it is essential to restrict the use to a single topical acne medication at any given time.

Emergency Situations In the event of accidental ingestion, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay.

Discontinuation of Use While specific instructions for discontinuation are not provided, it is prudent for users to consult their healthcare provider if they experience any adverse effects or have concerns regarding the use of this product.

Side Effects

Patients should be aware that this product is intended for external use only. The concurrent use of other topical acne medications, either simultaneously or immediately after applying this product, may lead to increased dryness or irritation of the skin. In such cases, it is recommended that only one medication be used unless otherwise directed by a healthcare professional.

For new users, a sensitivity test is advised. Patients should apply the product sparingly to one or two small affected areas during the first three days of use. If no discomfort is experienced, patients may proceed with the application as directed.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dermatouch Acnecare Facial Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product does not contain specific information regarding its use during pregnancy. There are no explicit warnings or contraindications mentioned for use during this period. Additionally, no dosage modifications for pregnant individuals are provided in the insert. Furthermore, there are no special precautions listed regarding the use of this product during pregnancy. Healthcare professionals should consider the absence of data when advising pregnant patients and weigh the potential benefits against any unknown risks.

Lactation

There are no specific statements or considerations regarding lactating mothers or lactation in the provided text. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk remain unspecified. Healthcare professionals should exercise caution and consider the absence of data when advising lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters have not been defined.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that the use of this product may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is important to counsel patients to use only one topical acne medication at a time to minimize the risk of irritation. If patients experience any signs of irritation, they should discontinue use and consult their healthcare provider for further guidance.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with an initial recommendation of one application daily. Patients may gradually increase the frequency to two or three times daily as needed or directed by a healthcare professional. Should bothersome dryness or peeling occur, it is advised to reduce the application frequency to once a day or every other day.

For new users, a sensitivity test is recommended: apply the product sparingly to one or two small affected areas for the first three days. If no discomfort arises, patients can proceed with the full application as directed. Clinicians should inform patients that the likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently. Therefore, it is advisable to use only one topical acne treatment at a time to minimize the risk of irritation.

Drug Information (PDF)

This file contains official product information for Dermatouch Acnecare Facial Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)